ArticleSurgery today2026
Long-term prognosis and postoperative liver atrophy after gastrectomy in patients with gastric cancer and liver cirrhosis.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGastrectomy in patients with liver cirrhosis is associated with an increased postoperative risk and poor prognosis; however, the long-term outcomes remain unclear. This study evaluated the survival of patients with cirrhosis after gastrectomy, focusing on postoperative nutritional deterioration and time-dependent survival effects.
methodsThis retrospective study included 847 patients who underwent gastrectomy for gastric cancer. Patients were categorized into liver cirrhosis (LC) and non-LC groups. One-to-four propensity score matching was performed to adjust for the baseline characteristics. Overall survival, cancer-specific survival, and postoperative liver volume changes were compared between the two groups. The time-dependent effects were examined using a piecewise-constant hazard model.
resultsAfter matching, overall survival was significantly worse in the LC group, whereas the cancer-specific survival did not differ between the groups. The survival disadvantage was most pronounced within the first postoperative year. An exploratory analysis demonstrated significant postoperative hepatic atrophy in patients with cirrhosis. Liver disease-related mortality, including hepatic failure and hepatocellular carcinoma, was significantly higher in the LC group.
conclusionsGastrectomy in patients with liver cirrhosis was associated with a worse overall survival, primarily because of liver disease-related mortality, whereas cancer-specific survival was comparable to that in patients without cirrhosis. A greater postoperative liver volume reduction has been observed in the patients with cirrhosis, although its mechanism and clinical significance remain unclear. Further prospective studies are warranted to determine whether nutritional or other perioperative interventions improve the postoperative outcomes.
Indexed as
Identifiers
42640324What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.